Cytek Biosciences, Inc. CTKB Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s total operating expenses?
- Cytek Biosciences, Inc. (CTKB) reported total operating expenses of $39.72M in Q1 2026.
- How has Cytek Biosciences, Inc.'s total operating expenses changed year-over-year?
- Cytek Biosciences, Inc.'s total operating expenses increased by 13.1% year-over-year, from $35.13M to $39.72M.
- What is the long-term trend for Cytek Biosciences, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s total operating expenses has grown at a 19.9% compound annual growth rate (CAGR), from $69.99M to $144.85M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.